Why the study?
Coronary angiography forms the basis of invasive management in NSTEACS, but contemporary data regarding national temporal trends in its utilization across different patient subgroups are limited.
What are the temporal trends and predictors of coronary angiography utilization, and does it reduce in-hospital mortality in patients with NSTEACS?
What are the temporal trends and predictors of coronary angiography utilization, and does it reduce in-hospital mortality in patients with NSTEACS?
While coronary angiography utilization for NSTEACS increased from 2004 to 2014 and is associated with lower in-hospital mortality, a risk-treatment paradox persists where older, female, and more comorbid patients are less likely to receive it.
Coronary angiography (CA) is the basis of an invasive management strategy in non-ST elevation acute coronary syndromes (NSTEACS). There are limited contemporary data on national temporal trends in utilization of CA in different patient subgroups. We sought to investigate temporal trends, predictors and clinical outcomes associated with the use of CA in the US. Using the Nationwide Inpatient Sample (NIS) from 2004–2014, we identified all inpatient admissions, age ≥18, with a primary diagnosis of NSTEACS. Descriptive statistics and multivariable logistic regression models were used to investigate temporal trends, predictors and clinical outcomes associated with CA. From a total of 4,380,827 patients, 57.5% received CA during the study period and were more likely to be male, younger and less comorbid as defined per Charlson comorbidity index. The proportion of patients receiving CA increased from 48.5% to 68.5%, however, higher proportional increase was observed in males (53.9% to 69.4% P trend < 0.001) and those age ≤60 years (59.0% to 77.9% P trend < 0.001). Prior history of CABG (OR 0.33 95%CI 0.35–0.36), previous PCI (OR 0.84 95%CI 0.83–0.86) and previous AMI (OR 0.65 95%CI 0.64–0.67) were inversely related with receipt of CA. Receipt of CA was strongly associated with decreased odds of in-hospital mortality (OR 0.38 95%CI 0.36–0.40). In this national analysis, we observed a temporal increase in utilization of CA albeit slower adoption was noted in older, women and more comorbid patients. The risk-treatment paradox wherein patients who are most likely to benefit were less likely to receive CA persists even in contemporary practice.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: